<DOC>
	<DOCNO>NCT00623376</DOCNO>
	<brief_summary>Objectives : To determine whether nabilone , synthetic cannabinoid , alleviate spasticity people spinal cord injury ( SCI ) . Methods : Twelve subject enrol double-blind , placebo-controlled , crossover study . They receive either nabilone placebo first four-week period ( 0.5mg OD option increase 0.5mg BID ) , outcome measure assess . After two-week washout , subject crossed-over opposite arm . The primary outcome Ashworth scale spasticity involve muscle group , choose subject clinician . The secondary outcome include Spasm Frequency Scale , Visual Analog Scale , Wartenberg Pendulum Test , sum Ashworth Scale eight muscle group side body , Clinician 's Subject 's Global Impression Change .</brief_summary>
	<brief_title>Randomized Double Blind Cross Over Study Nabilone Spasticity Spinal Cord Injury Persons</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Nabilone</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Patients spinal cord injury eligible study 1865 year old , C5 ( ASIA AD ) injury occur great 1 year previously . They stable neurological level injury moderate spasticity ( Ashworth &gt; /= 3 ) cognitive impairment . The spasticity medication need unchanged least 30 day inclusion , botulinum toxin injection &gt; 4 month . They exclude : Heart disease cannabinoids reduce heart rate blood pressure History psychotic disorder , schizophrenia active psychological disorder Previously document sensitivity marijuana cannabinoid agent Severe liver dysfunction Cognitive impairment Major illness another body area If pregnant nursing mother Had history drug dependency Used smoke cannabis &lt; 30 day onset study unwilling smoke study ; OR If fix tendon contracture</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>